SCHEMBL19248489

SCHEMBL19248489

CCc1ccc(COC(=O)c2ccccc2)c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.56
TDP1 Q9NUW8 2/20 0.56
SLC6A2 P23975 1/20 0.56
SLC6A3 Q01959 1/20 0.56
LMNA P02545 2/20 0.54
PPARG P37231 1/20 0.54
RAB9A P51151 4/20 0.48
MAPK1 P28482 3/20 0.48
NPC1 O15118 3/20 0.48
MAPT P10636 2/20 0.48
MEN1 O00255 1/20 0.48
CASP3 P42574 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
TSHR P16473 2/20 0.47
HIF1A Q16665 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
HPGD P15428 1/20 0.45
GAA P10253 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17537989 0.93 TDP1 (0.63) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL5085480 0.80 PPARG (0.71) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL5083020 0.78 PPARG (0.63) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL23134300 0.77 KMT2A (0.79) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL6243415 0.77 PPARG (0.63) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL23228451 0.77 PPARG (0.67) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL4645175 0.77 TDP1 (0.66) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL29853739 0.77 TDP1 (0.66) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL28683734 0.76 TDP1 (0.51) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL471706 0.76 PPARG (0.61) KMT2ATDP1SLC6A2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093939-A9 NOVEL MONOMERS FROM BIOMASS NDSU RESEARCH FOUNDATION (US) 2018-04-05 US disclosed
US-20170233325-A1 NOVEL MONOMERS FROM BIOMASS NDSU RESEARCH FOUNDATION (US) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093939-A9 NOVEL MONOMERS FROM BIOMASS DCXR, MANBA, PGLS KMT2A 4022/4885TDP1 2448/4885SLC6A2 4871/4885
US-20170233325-A1 NOVEL MONOMERS FROM BIOMASS DCXR, MANBA, PGLS KMT2A 4022/4885TDP1 2448/4885SLC6A2 4871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.